Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer
9/28/2007 11:33:44 AM
STOCKHOLM, Sweden, September 26, 2007. Swedish MPA gives go ahead for the clinical trial of Affibody’s molecular imaging agent designed to improve the diagnosis of HER2-positive breast cancer.
comments powered by